𝔖 Bobbio Scriptorium
✦   LIBER   ✦

Analysis of inhibitor binding in influenza virus neuraminidase

✍ Scribed by Brian J. Smith; Peter M. Colman; Mark Von Itzstein; Basil Danylec; Joseph N. Varghese

Book ID
111753394
Publisher
Cold Spring Harbor Laboratory Press
Year
2001
Tongue
English
Weight
454 KB
Volume
10
Category
Article
ISSN
0961-8368

No coin nor oath required. For personal study only.

πŸ“œ SIMILAR VOLUMES

Development of neuraminidase inhibitors
Development of neuraminidase inhibitors as anti-influenza virus drugs
✍ Joseph N. Varghese πŸ“‚ Article πŸ“… 1999 πŸ› John Wiley and Sons 🌐 English βš– 749 KB

Structure-based design and synthesis of potent influenza virus neuraminidase inhibitors are now being evaluated in human trials as anti-influenza virus drugs. The first drug of this class, Relenzaβ„’ (Zanamivir/GG167), is now awaiting pharmaceutical evaluation and registration in Australia, Europe, an

Neuraminidase inhibitor resistance in in
Neuraminidase inhibitor resistance in influenza viruses
✍ Phillip Andrew Reece πŸ“‚ Article πŸ“… 2007 πŸ› John Wiley and Sons 🌐 English βš– 145 KB

## Abstract Zanamivir and oseltamivir, the currentlymarketed influenza virus neuraminidase inhibitors (NAIs), are prescribed for the treatment and prophylaxis of influenza and are being stockpiled for pandemic influenza. Oseltamivir resistance has been reported in up to 2% of patients in clinical t